HomeIndustriesHealthcareBlue Cross Blue Shield Drops Coverage of GLP-1 Obesity Drugs

Blue Cross Blue Shield Drops Coverage of GLP-1 Obesity Drugs

Blue Cross Blue Shield of Michigan dropped coverage of GLP-1 obesity drugs. Renita Young discusses this as BCBS says weight-loss drugs are cut due to “efficacy, safety and access, and cost.” Tune in to find out more about the stock market today.

Market On Close

12 Jun 2024

SHARE

ON AIR
12:30 am
Market Overtime
replay
5:00 am
Trading 360
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Next Gen Investing
REPLAY
education
8:00 am
Your First Trade
REPLAY
education
8:30 am
Inside the Mind of a Trader
REPLAY
education
9:00 am
Inside the Mind of a Trader
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Your First Trade
REPLAY
education
10:30 am
Your First Trade
REPLAY
11:00 am
Market Overtime
REPLAY
11:30 am
Market Overtime
REPLAY
education
12:00 pm
Inside the Mind of a Trader
REPLAY
education
12:30 pm
Inside the Mind of a Trader
REPLAY
education
1:00 pm
Inside the Mind of a Trader
REPLAY
1:30 pm
Market Overtime
REPLAY
education
2:00 pm
Your First Trade
REPLAY
education
2:30 pm
Your First Trade
REPLAY
education
3:00 pm
Your First Trade
REPLAY
education
3:30 pm
Your First Trade
REPLAY
education
4:00 pm
Your First Trade
REPLAY
education
4:30 pm
Your First Trade
REPLAY
education
5:00 pm
Your First Trade
REPLAY
education
5:30 pm
Your First Trade
REPLAY
education
6:00 pm
Your First Trade
REPLAY
education
6:30 pm
Your First Trade
REPLAY
7:00 pm
Trading 360
REPLAY
8:00 pm
Fast Market
REPLAY
9:00 pm
Next Gen Investing
REPLAY
10:00 pm
Market Overtime
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Inside the Mind of a Trader
REPLAY
12:00 am
Market Overtime
REPLAY
ON AIR
12:30 am
Market Overtime
REPLAY
1:00 am
Market Overtime
REPLAY
1:30 am
Market Overtime
REPLAY
2:00 am
Trading 360
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor